The terminal is fine. But if you actually want to live in your Hermes agent, here are the four best GUIs the community has ...
Google launches AI agent suite at Cloud Next 2026 with Workspace Studio, A2A protocol at 150 orgs, and Project Mariner. The pitch: only Google owns the full stack.
Stacker compiled data on the top feature-length films from the past 100 years, crowning a champion for each year using ...
It means that, in the next earthquake, this building could fall down,” Radu Jude, the Romanian film director, explained to me recently, when I met him in the capital, his native city. It’s been ...
TypeScript 7 Beta is here, bringing native execution speed and shared-memory parallelism to Visual Studio. Experience a 10x speed boost and snappier IntelliSense today.
Microsoft's Data API Builder is designed to help developers expose database objects through REST and GraphQL without building a full data access layer from scratch. In this Q&A, Steve Jones previews ...
Pradershika Sharma is a tech deals writer for Lifehacker. She has a Master’s degree in English Literature, a B.Ed., and a TESOL certification. She has been writing professionally since 2018, creating ...
At just 300 sqft, this Melbourne studio challenges the idea that small spaces need to be open and simple. Instead, it’s divided into a series of distinct zones using changes in height and material.
System administrators are moving into an era where AI tools are woven into daily responsibilities. From automating routine maintenance to analyzing logs and forecasting issues, AI is redefining IT ...
In Nebraska’s Senate race, a Trump-supporting, anti-abortion pastor is running as a Democrat. The state’s Democratic Party — which is backing an independent candidate — says he’s a Republican plant.
Microsoft Visual Studio Pro 2026 Is Now $43 (MSRP $499.99) You're getting a full-featured development environment with AI tools and collaboration built in at an outstanding discount.
May 4, 2026 Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review ...